Table 4 Features of cardiac valvular involvement of untreated TA patients with positive or negative ASO
Valvular involvement | ASO positive n = 13 | ASO negative n = 61 | P-Value |
|---|---|---|---|
Total, n(%) | 10 (76.9) | 40 (65.6) | 0.427 |
Aortic Valve insufficiency, n(%) | 6 (46.2) | 24 (39.3) | 0.650 |
 Mild | 4 (30.8) | 18 (29.5) | 0.828 |
 Medium to severe | 2 (15.4) | 6 (9.8) | 0.559 |
Mitral valve insufficiency, n(%) | 9 (69.2) | 29 (47.5) | 0.155 |
 Mild | 5 (38.5) | 28 (45.9) | 0.624 |
 Medium to severe | 4 (30.8) | 1 (1.6) | 0.000 |
Mitral valve stenosis, n(%) | 1 (7.7) | 1 (1.6) | 0.222 |
Tricuspid valve insufficiency, n(%) | 6 (46.2) | 16 (26.2) | 0.154 |
 Mild | 4 (30.8) | 17 (27.9) | 0.833 |
 Medium to severe | 2 (15.4) | 1 (1.6) | 0.023 |
Pulmonary insufficiency (mild), n(%) | 1 (7.7) | 1 (1.6) | 0.222 |
Multiple valve involvement, n(%) | 8 (61.5) | 21 (34.4) | 0.069 |
Single valve involvement, n(%) | 2 (15.4) | 19 (31.2) | 0.252 |